Cargando…
Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
Autores principales: | Singh, Awadhesh Kumar, Singh, Ritu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836896/ https://www.ncbi.nlm.nih.gov/pubmed/32533990 http://dx.doi.org/10.1016/j.diabres.2020.108268 |
Ejemplares similares
-
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020) -
Metformin in gestational diabetes: An emerging contender
por: Singh, Awadhesh Kumar, et al.
Publicado: (2015) -
Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes
por: Singh, Awadhesh K, et al.
Publicado: (2021) -
COVID-19 experience in Kuwait: A high prevalence of asymptomatic cases and increased mortality in smokers
por: Singh, Awadhesh Kumar
Publicado: (2020) -
Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)